Prostate Cancer Program News

 

Prostate Cancer Program 2022 Pilot Research Awards

APPLICATION MATERIALS: 2022 PILOT RESEARCH AWARDS

Questions about this award program may be directed to [email protected].

The UCSF Prostate Cancer Program seeks to fund pilot projects in prostate cancer research. All areas of prostate cancer research, including computational, laboratory, translational, clinical, and population science, are eligible. Please refer to the complete RFA for details, including 2022 funding priorities.

Award Amount

  • Basic awards: $40,000
  • Transdisciplinary multi-investigator awards: Up to $85,000

Important Dates

  • Application deadline:  May 8, 2022
  • Award term: 12 months, beginning May 30-July 1, 2022

Eligible Applicants

  • UCSF Faculty, including Adjunct Professors and Instructors
  • UCSF Learners/Trainees and other non-Faculty
  • Any UC Berkeley and UC Santa Cruz personnel, collaborating with a member of UCSF’s Prostate Cancer Program

 Investigators who have received Prostate Cancer Program pilot funding since 2018 are not eligible.

Award Selection

All applications will be reviewed by UCSF’s Prostate Cancer Program Leadership Committee in the selection of multiple proposals for funding. 

Program Events

Upcoming Events

Prostate Cancer Program Annual Scientific Retreat

Sep 23, 2022 | Details and registration to be announced

2022 Patient Conference on Prostate Cancer

October 15, 2022 | Co-hosted by the California Prostate Cancer Coalition, this conference was designed to help patients think about their care, discuss their case with their own doctors and others, and join in effective informed decision-making.


Past Events

Prostate Cancer Program Research Workshop

Nov 17, 2021 | Topic: Beyond PSMA Lutetium Approval: the Unanswered Questions

HDFCCC Research Symposium: Challenges and Opportunities in Prostate Cancer Immunotherapy

June 30, 2021 | Jointly presented by the Cancer Immunology & Immunotherapy Program and the Prostate Cancer Program of the Helen Diller Family Comprehensive Cancer Center

2021 Patient Conference on Prostate Cancer

May 14, 2021 | Co-hosted by the California Prostate Cancer Coalition, this conference was designed to help patients think about their care, discuss their case with their own doctors and others, and join in effective informed decision-making.

Prostate Cancer Program Funded Research

2021 Funded Research

  • Rebecca Graff, ScD
    Metabolomic Disparities Between Black and White Men with Metastatic Prostate Cancer
  • Haolong Li, PhD
    Investigating PTGES3 as a Novel Therapeutic Target in Advanced Prostate Cancer
  • Osama Mohamad, MD, PhD
    Artificial Intelligence-Based Tools to Improve Decision Making for Patients with Prostate Cancer on Active Surveillance
  • Duygu Kuzuoglu Oztur, PhD
    Elucidating the Roles of Different 5'UTRs of AR mRNA in Prostate Cancer
  • Jingjing Li, PhD
    Single-Cell Analysis of Germline Mutations Conferring Population Disparities in Prostate Cancer
  • Li Zhang, PhD
    Quantification of Adaptive Immune Response to Pembrolizumab for mCRPC Patients

2019 Funded Research

  • Nam Woo Cho, MD, PhD
    Systematic Dissection of Anti-Tumor Immunity Against Mismatch Repair-Deficient Prostate Cancer
  • Crystal Langlais, MPH
    Development and Examination of Post-Diagnostic Lifestyle Scores for the Prevention of Prostate Cancer Progression
  • Jingjing Li, PhD
    Deep Learning to Identify the Altered Chromatin Architecture from Large-Scale Prostate Cancer Genomes
  • Ruhollah Moussavi-Baygi, PhD
    An in-silico Functional Genomics Approach for Determining Drivers of mCRPC in Individual Patients
  • David Quigley, PhD
    Etiology and Therapeutic Vulnerabilities of Hypermethylated Metastatic Prostate Tumors

2018 Funded Research

  • Rohit Bose, MD, PhD
    Key Tumor Suppressors in Prostate Cancer Lacking ETS Fusions
  • MinKyu Kim, PhD and Jonathan Chou, MD, PhD
    Mapping the Therapeutic Vulnerabilities of CDK12-Mutated Prostate Cancer
  • Renuka Sriram, PhD
    Metabolic Characterization of Prostate Cancer Bone Metastatic Phenotypes Using Hyperpolarized 13C MRI -  Improved Assessment of Therapeutic Response

2017 Funded Research

  • Mekhail Anwar, MD, PhD
    A Microfabricated Imaging Platform for Intraoperative Detection of Microscopic Nodal and Margin Involvement in Prostate Cancer
  • Robert Flavell, MD, PhD
    Boronated PSMA Neutron Capture Therapy for Treatment of Advanced Prostate Cancer
  • Luke Gilbert, PhD
    Engineering an Expanded Therapeutic Window for Imaging and Treating Metastatic Prostate Cancer
  • Hani Goodarzi, PhD
    Systematic Identification of Post-Transcriptional Regulatory Pathways that Drive Prostate Cancer
  • Jim Wells, PhD
    Characterizing and Targeting the MYC Surface-ome in Advanced Prostate Cancer

 

Benioff Initiative for Prostate Cancer Research

The mission of the UCSF Benioff Initiative for Prostate Cancer Research is to understand the fundamental biology underlying aggressive prostate cancer and develop strategies that will lead to a cure for metastatic disease.